Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kyula JN"'
Autor:
McLaughlin M; The Institute of Cancer Research, London, UK., Pedersen M; The Institute of Cancer Research, London, UK., Roulstone V; The Institute of Cancer Research, London, UK., Bergerhoff KF; The Institute of Cancer Research, London, UK., Smith HG; The Institute of Cancer Research, London, UK., Whittock H; The Institute of Cancer Research, London, UK., Kyula JN; The Institute of Cancer Research, London, UK., Dillon MT; The Institute of Cancer Research, London, UK., Pandha HS; University of Surrey, Guildford, UK., Vile R; Mayo Clinic, Rochester, MN, USA., Melcher AA; The Institute of Cancer Research, London, UK., Harrington KJ; The Institute of Cancer Research, London, UK.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2020 Jan 17; Vol. 16, pp. 238-249. Date of Electronic Publication: 2020 Jan 17 (Print Publication: 2020).
Autor:
Thomas S; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA., Kuncheria L; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA., Roulstone V; Institute for Cancer Research, London, UK., Kyula JN; Institute for Cancer Research, London, UK., Mansfield D; Institute for Cancer Research, London, UK., Bommareddy PK; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA., Smith H; Institute for Cancer Research, London, UK., Kaufman HL; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA., Harrington KJ; Institute for Cancer Research, London, UK., Coffin RS; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA. Rob@replimune.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Aug 10; Vol. 7 (1), pp. 214. Date of Electronic Publication: 2019 Aug 10.
Autor:
Hafsi H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Dillon MT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Barker HE; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Kyula JN; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Schick U; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Radiation Oncology Department, University Hospital Morvan, Brest, France., Paget JT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Smith HG; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., McLaughlin M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2018 Jul 13; Vol. 8, pp. 245. Date of Electronic Publication: 2018 Jul 13 (Print Publication: 2018).
Autor:
Khan AA; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK.; Department of Plastic Surgery, The Royal Marsden Hospital, London SW3 6JJ, UK., Paget JT; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK.; Department of Plastic Surgery, The Royal Marsden Hospital, London SW3 6JJ, UK., McLaughlin M; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Kyula JN; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Wilkinson MJ; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Pencavel T; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Mansfield D; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Roulstone V; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Seth R; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Halle M; Department of Molecular Medicine and Surgery, Section of Plastic Surgery, Karolinska Institute, Stockholm 17176, Sweden.; Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Stockholm 17176, Sweden., Somaiah N; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Boult JKR; Magnetic Resonance Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK., Robinson SP; Magnetic Resonance Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK., Pandha HS; Postgraduate Medical School, University of Surrey, Guildford GU2 7XH, UK., Vile RG; Molecular Medicine Program, Mayo Clinic, Rochester, MN 55905, USA., Melcher AA; Translational Immunotherapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK., Harris PA; Department of Plastic Surgery, The Royal Marsden Hospital, London SW3 6JJ, UK., Harrington KJ; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK. kevin.harrington@icr.ac.uk.
Publikováno v:
Science translational medicine [Sci Transl Med] 2018 Jan 24; Vol. 10 (425).
Autor:
McLaughlin M; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK. martin.mclaughlin@icr.ac.uk., Barker HE; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Khan AA; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Pedersen M; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Dillon M; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Mansfield DC; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Patel R; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Kyula JN; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Bhide SA; The Royal Marsden Hospital, 203 Fulham Road, London, SW3 6JJ, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, 237 Fulham Road, London, UK., Newbold KL; The Royal Marsden Hospital, 203 Fulham Road, London, SW3 6JJ, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, 237 Fulham Road, London, UK., Nutting CM; The Royal Marsden Hospital, 203 Fulham Road, London, SW3 6JJ, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, 237 Fulham Road, London, UK., Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.; The Royal Marsden Hospital, 203 Fulham Road, London, SW3 6JJ, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, 237 Fulham Road, London, UK.
Publikováno v:
BMC cancer [BMC Cancer] 2017 Jan 31; Vol. 17 (1), pp. 86. Date of Electronic Publication: 2017 Jan 31.
Autor:
McEntee G; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Kyula JN; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Mansfield D; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Smith H; Targeted Therapy Team, The Institute of Cancer Research, London, UK.; Sarcoma/Melanoma Unit, Department of Academic Surgery, Royal Marsden Hospital NHS Foundation Trust, London, UK., Wilkinson M; Targeted Therapy Team, The Institute of Cancer Research, London, UK.; Sarcoma/Melanoma Unit, Department of Academic Surgery, Royal Marsden Hospital NHS Foundation Trust, London, UK., Gregory C; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Roulstone V; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Coffey M; Oncolytics Biotech Inc., Calgary, Canada., Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, London, UK.
Publikováno v:
Oncotarget [Oncotarget] 2016 Jul 26; Vol. 7 (30), pp. 48517-48532.
Autor:
Mansfield DC; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Kyula JN; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Rosenfelder N; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Chao-Chu J; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Kramer-Marek G; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Khan AA; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Roulstone V; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., McLaughlin M; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK., Melcher AA; Leeds Institute of Cancer and Pathology, University of Leeds, St James's University Hospital, Leeds, UK., Vile RG; Molecular Medicine Program, Mayo Clinic, Rochester, MN, USA., Pandha HS; Postgraduate Medical School, The University of Surrey, Guildford, UK., Khoo V; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK.; The Royal Marsden Hospital, London, UK.; University of Melbourne and Monash University, Victoria, Australia., Harrington KJ; Divisions of Cancer Biology and Radiotherapy and Imaging, The Institute of Cancer Research, Chester Beatty Labs, London, UK.; The Royal Marsden Hospital, London, UK.
Publikováno v:
Gene therapy [Gene Ther] 2016 Apr; Vol. 23 (4), pp. 357-68. Date of Electronic Publication: 2016 Jan 27.
Autor:
Seth R; London, Surrey, and Leeds, United Kingdom; and Rochester, Minn. From the Targeted Therapy Team, Institute of Cancer Research; the Department of Plastic Surgery, Royal Marsden Hospital; the Postgraduate Medical School, University of Guildford; the Leeds Institute of Molecular Medicine; and the Molecular Medicine Program, Mayo Clinic., Khan AA, Pencavel TD, Wilkinson MJ, Kyula JN, Simpson G, Pandha H, Melcher A, Vile R, Harris PA, Harrington KJ
Publikováno v:
Plastic and reconstructive surgery [Plast Reconstr Surg] 2015 Feb; Vol. 135 (2), pp. 475-487.
Autor:
Kyula JN; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Khan AA; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Mansfield D; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Karapanagiotou EM; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., McLaughlin M; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Roulstone V; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Zaidi S; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Pencavel T; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Touchefeu Y; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Seth R; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK., Chen NG; Genelux Corp, San Diego Science Center, San Diego, CA, USA., Yu YA; Genelux Corp, San Diego Science Center, San Diego, CA, USA., Zhang Q; Genelux Corp, San Diego Science Center, San Diego, CA, USA., Melcher AA; Leeds Institute of Molecular Medicine, Leeds, UK., Vile RG; 1] Leeds Institute of Molecular Medicine, Leeds, UK [2] Molecular Medicine Program, Mayo Clinic, Rochester, MN, USA., Pandha HS; Postgraduate Medical School, The University of Surrey, Guildford, UK., Ajaz M; Postgraduate Medical School, The University of Surrey, Guildford, UK., Szalay AA; Genelux Corp, San Diego Science Center, San Diego, CA, USA., Harrington KJ; Targeted Therapy Team, Divisions of Cancer Biology, The Institute of Cancer Research, London, UK.
Publikováno v:
Oncogene [Oncogene] 2014 Mar 27; Vol. 33 (13), pp. 1700-12. Date of Electronic Publication: 2013 Apr 29.
Autor:
Kyula JN; Department of cancer biology, Institute of Cancer Research, London., Khan AA, Wilkinson MJ, Mansfield D, Harrington KJ
Publikováno v:
Oncotarget [Oncotarget] 2013 Sep; Vol. 4 (9), pp. 1329-30.